Youth Epilepsy and Successful Self-Management Intervention
NCT03639233 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2019-10-30
Summary
This study is designed as a pilot test of the YESS! web-based intervention for adolescents with epilepsy. One hundred twenty participants will be given access to the intervention for a period of eight weeks. The investigators are testing the feasibility and acceptability of the the study procedures, measures and of the intervention itself. The study also evaluats the potential for impact on the users.
Conditions
Interventions
- BEHAVIORAL
-
YESS!
Web based self-management education
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Peter Scal, MD MPH · University of Minnesota
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-09-01
Countries
- United States
Study Locations
More Related Trials
-
Behavioral and Educational Tools to Improve Epilepsy Care
NCT02646631 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of a Mobile Epilepsy Education Application
NCT06402526 ·Status: COMPLETED ·Phase: NA
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications
NCT05321641 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT02224690 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
NCT02318537 ·Status: WITHDRAWN ·Phase: PHASE3
-
Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
NCT02362373 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Intervention for Pediatric Epilepsy
NCT02514291 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
NCT06769659 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy
NCT00550940 ·Status: COMPLETED
-
A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects
NCT01918735 ·Status: COMPLETED ·Phase: PHASE1
-
Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy
NCT06661759 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
NCT01747915 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
NCT04938427 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Progesterone vs Placebo Therapy for Women With Epilepsy
NCT00029536 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
NCT03355209 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Cognitive Behavioral Play Intervention and Epilepsy
NCT06813612 ·Status: RECRUITING ·Phase: NA
-
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT05772429 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
NCT03650452 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
NCT02171234 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures
NCT00465517 ·Status: COMPLETED ·Phase: PHASE2